TREM-1-targeting LP17 attenuates cerebral ischemia-induced neuronal injury by inhibiting oxidative stress and pyroptosis

Yu-Bin Liang,Ping-Ping Song,Yun-Hui Zhu,Jia-Min Xu,Pei-Zhi Zhu,Rong-Rong Liu,Yu-Sheng Zhang

DOI: https://doi.org/10.1016/j.bbrc.2020.05.056

IF: 3.1

2020-08-01

Biochemical and Biophysical Research Communications

Abstract:Stroke ranks as the second leading cause of disability and death globally. Trigger receptors expressed on myeloid cells (TREM) −1 are responsible for the activation of the innate immune response and also play a critical role in inflammation. In this study, we reported the contribution of TREM-1 after ischemic damage in a rat middle cerebral artery occlusion (MCAO) model. This study also demonstrated that TREM-1 expression was upregulated following cerebral infarction in rats. TREM-1 inhibition was determined using its selective inhibitor, LP17, which indicated a neuroprotective effect on cerebral infarction damage. The findings revealed that inhibition of TREM-1 by administering LP17 improved cerebral damage and decreased ischemic areas and brain water contents. Moreover, LP17 decreased MCAO-induced microglial activation and neurodegeneration, evidenced by a reduction in the expression of microglial Iba-1 and FJ-B positive cells, and reversed neuronal loss. Besides, the contribution of LP17 to ischemic neuronal damage may be associated with a decrease in the production of pro-inflammatory cytokines, and enhanced production of anti-inflammatory cytokine IL-10. Both in vivo and in vitro studies showed that inhibiting TREM-1 attenuated ROS accumulation, lipid per-oxidation (LPO) contents such as malondialdehyde (MDA) and enhanced the superoxide dismutase (SOD) activity after ischemia. Inhibiting TREM-1 alleviated inflammation and pyroptosis found in MCAO rats. This was achieved through the inhibition of the levels of NLRP3, caspase-1, ASC (an apoptosis-associated speck-like protein containing a CARD) and gasdermin D. These results confirmed that inhibiting TREM-1 protects against ischemia-induced neuronal damage and alleviates microglial mediated neuro-inflammation by reducing oxidative stress and pyroptosis. Therefore, blocking TREM-1 expression provides an effective intervention for improving ischemic stroke.

biochemistry & molecular biology,biophysics

What problem does this paper attempt to address?

The problems that this paper attempts to solve are: **To explore the role of TREM - 1 in ischemic stroke (ischemic stroke), and to verify whether inhibiting TREM - 1 can reduce ischemia - induced neuronal damage by reducing oxidative stress and pyroptosis.** Specifically, the researchers focused on: 1. **Expression and activation of TREM - 1**: The study found that in the middle cerebral artery occlusion (MCAO) model in rats, the expression of TREM - 1 increased significantly after ischemia. This indicates that TREM - 1 may play an important role in ischemic brain injury. 2. **The role of oxidative stress and pyroptosis**: Ischemic stroke can lead to oxidative stress and inflammatory responses, which in turn cause neuronal damage. The activation of TREM - 1 is considered to be closely related to these pathological processes. Therefore, inhibiting TREM - 1 may help to reduce these harmful effects. 3. **The therapeutic effect of LP17**: By using LP17, a selective inhibitor of TREM - 1, the researchers hope to verify whether it can effectively improve ischemic brain injury, reduce infarct volume, decrease brain water content, and improve neurological deficits. ### Summary of the main problems in the study: - **What is the specific role of TREM - 1 in ischemic stroke?** - **Can inhibiting TREM - 1 reduce ischemia - induced neuronal damage?** - **What is the effect of LP17 as a TREM - 1 inhibitor?** ### Key conclusions: - Inhibiting TREM - 1 can significantly reduce ischemic brain injury, infarct volume and brain water content. - After LP17 treatment, the levels of ROS, MDA, and LPO decreased, and the activities of SOD and HO - 1 increased, indicating that oxidative stress was alleviated. - The inhibition of TREM - 1 reduced the expression of pyroptosis - related molecules such as NLRP3, caspase - 1, and GSDMD, thereby reducing pyroptosis. - By inhibiting TREM - 1, LP17 can improve neurological deficits, reduce microglial activation and neuronal loss. These results indicate that **inhibiting TREM - 1 may be a potential target for the treatment of ischemic stroke**, and LP17, as an effective TREM - 1 inhibitor, shows good therapeutic prospects.

TREM-1-targeting LP17 attenuates cerebral ischemia-induced neuronal injury by inhibiting oxidative stress and pyroptosis

TREM2 Protects Against Cerebral Ischemia/reperfusion Injury

TREM2 Activation Attenuates Neuroinflammation and Neuronal Apoptosis Via PI3K/Akt Pathway after Intracerebral Hemorrhage in Mice.

TREM-1 Exacerbates Neuroinflammatory Injury Via NLRP3 Inflammasome-Mediated Pyroptosis in Experimental Subarachnoid Hemorrhage

Microglial TREM-1 Receptor Mediates Neuroinflammatory Injury Via Interaction with SYK in Experimental Ischemic Stroke.

TREM (Triggering Receptor Expressed on Myeloid Cells)-1 Inhibition Attenuates Neuroinflammation via PKC (Protein Kinase C) δ/CARD9 (Caspase Recruitment Domain Family Member 9) Signaling Pathway After Intracerebral Hemorrhage in Mice.

Peripheral TREM1 responses to brain and intestinal immunogens amplify stroke severity

TREM2 regulates microglial lipid droplet formation and represses post-ischemic brain injury

TREM2 Impairs Glycolysis to Interrupt Microglial M1 Polarization and Inflammation via JAK2/STAT3 Axis

TREM2 improves neurological dysfunction and attenuates neuroinflammation, TLR signaling and neuronal apoptosis in the acute phase of intracerebral hemorrhage

Astrocyte-TREM2 alleviates brain injury by regulating reactive astrocyte states following ischemic stroke

TREM1 promotes neuroinflammation after traumatic brain injury in rats: Possible involvement of ERK/cPLA2 signalling pathway

Endothelial TREM‐1 receptor regulates the blood–brain barrier integrity after intracerebral hemorrhage in mice via SYK/β‐catenin signaling

Inhibition of TREM-1 alleviates neuroinflammation by modulating microglial polarization via SYK/p38MAPK signaling pathway after traumatic brain injury

TREM2 alleviates long-term cognitive dysfunction after subarachnoid hemorrhage in mice by attenuating hippocampal neuroinflammation via PI3K/Akt signaling pathway

TREM2 Alleviates Subarachnoid Hemorrhage-Induced Brain Injury through Attenuating Neuroinflammation and Programmed Cell Death in Vivo and in Vitro

TREM2 Modulates Neuroinflammation with Elevated IRAK3 Expression and Plays a Neuroprotective Role after Experimental SAH in Rats.

sTREM-1 promotes the phagocytic function of microglia to induce hippocampus damage via the PI3K–AKT signaling pathway

Anti-inflammatory and neuroprotective effects of Triptolide via the NF-κB signaling pathway in a rat MCAO model.

TREM-1 inhibition or ondansetron administration ameliorates NLRP3 inflammasome and pyroptosis in traumatic brain injury-induced acute lung injury

TREM1 Regulates Neuroinflammatory Injury by Modulate Proinflammatory Subtype Transition of Microglia and Formation of Neutrophil Extracellular Traps via Interaction With SYK in Experimental Subarachnoid Hemorrhage